黄芪-三七成分药理作用干预ARDS分子机制的研究进展  

Research Progress on Mechanism of Astragalus and Panax Notoginseng in Intervention of ARDS

作　　者：叶晓滨 陈玉梅[2] YE Xiao-bin;CHEN Yu-mei(Xiamen Siming District Yuandang Community Health Service Center,Xiamen,Fujian 361012;Xiamen Hospital of Traditional Chinese Medicine,Xiamen,Fujian 361009)

机构地区：[1]厦门市思明区筼筜街道社区卫生服务中心,福建厦门361012 [2]厦门市中医院,福建厦门361009

出　　处：《按摩与康复医学》2022年第11期58-61,66,共5页Chinese Manipulation and Rehabilitation Medicine

摘　　要：急性呼吸窘迫综合征(Acute respiratory distress syndrome,ARDS)是指有心源性除外的各种肺内外因素所致的急性、低氧性呼吸功能不全或衰竭,在临床上发生率及患者的死亡率均较高,严重影响人们的生活质量。以往对于ARDS的治疗多采用支持性治疗,但其治疗费用较高,且毒副作用明显,给患者带来了很大的经济压力。近年来,药物治疗得到了广泛的应用。其中黄芪和三七的药用价值较高,因此本文针对ARDS的发病机制,以及黄芪和三七的医学功效,对含有黄芪-三七活性成分的中成药对于预防ARDS的积极性进行探究。Acute respiratory distress syndrome(ARDS)refers to acute and hypoxic respiratory insufficiency or failure caused by various pulmonary and extrapulmonary factors except cardiogenic.The clinical incidence and mortality of ARDS are high,which seriously affects people's quality of life.In the past,supportive treatment was used in the treatment of ARDS,but its treatment cost was high,and the side effects were obvious,which brought great economic pressure to the patients.In recent years,drug therapy has been widely used.Astragalus membranaceus and Panax notoginseng are of high medicinal value.Therefore,in view of the pathogenesis of ARDS and the medical efficacy of Astragalus and Panax notoginseng,Chinese patent medicines containing active ingredients of Astragalus membranaceus and Panax notoginseng are active in preventing ARDS.

关 键 词：急性呼吸窘迫综合征(ARDS) 黄芪 三七 中成药 预防 

分 类 号：R563.8[医药卫生—呼吸系统]